Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography
Open Access
- 31 December 2014
- Vol. 5 (4), e007516
- https://doi.org/10.1136/bmjopen-2014-007516
Abstract
Objectives: To assess the feasibility of a novel diagnostic algorithm targeting patients with risk factors for chronic liver disease in a community setting. Design: Prospective cross-sectional study. Setting: Two primary care practices (adult patient population 10 479) in Nottingham, UK. Participants: Adult patients (aged 18 years or over) fulfilling one or more selected risk factors for developing chronic liver disease: (1) hazardous alcohol use, (2) type 2 diabetes or (3) persistently elevated alanine aminotransferase (ALT) liver function enzyme with negative serology. Interventions: A serial biomarker algorithm, using a simple blood-based marker (aspartate aminotransferase: ALT ratio for hazardous alcohol users, BARD score for other risk groups) and subsequently liver stiffness measurement using transient elastography (TE). Main outcome measures: Diagnosis of clinically significant liver disease (defined as liver stiffness >= 8 kPa); definitive diagnosis of liver cirrhosis. Results: We identified 920 patients with the defined risk factors of whom 504 patients agreed to undergo investigation. A normal blood biomarker was found in 62 patients (12.3%) who required no further investigation. Subsequently, 378 patients agreed to undergo TE, of whom 98 (26.8% of valid scans) had elevated liver stiffness. Importantly, 71/98 (72.4%) patients with elevated liver stiffness had normal liver enzymes and would be missed by traditional investigation algorithms. We identified 11 new patients with definite cirrhosis, representing a 140% increase in the number of diagnosed cases in this population. Conclusions: A non-invasive liver investigation algorithm based in a community setting is feasible to implement. Targeting risk factors using a non-invasive biomarker approach identified a substantial number of patients with previously undetected cirrhosis.This publication has 45 references indexed in Scilit:
- Alcohol consumption screening of newly-registered patients in primary care: a cross-sectional analysisBritish Journal of General Practice, 2013
- Predictive value of ALT levels for non‐alcoholic steatohepatitis (NASH) and advanced fibrosis in non‐alcoholic fatty liver disease (NAFLD)Liver International, 2013
- Developing a ‘traffic light’ test with potential for rational early diagnosis of liver fibrosis and cirrhosis in the communityBritish Journal of General Practice, 2012
- Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohortJournal of Hepatology, 2012
- Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)BMC Gastroenterology, 2010
- Performance of Transient Elastography for the Staging of Liver Fibrosis: A Meta-AnalysisGastroenterology, 2008
- Utilization rates, complications and costs of percutaneous liver biopsy: a population‐based study including 4275 biopsiesLiver International, 2008
- Surveillance of cirrhosis for hepatocellular carcinoma: a cost–utility analysisBritish Journal of Cancer, 2008
- FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and fibrotestHepatology, 2007
- A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis CHepatology, 2003